Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2012
08/23/2012US20120216320 Method for modulating plant growth, nucleic acid molecules and polypeptides encoded thereof useful as modulating agent
08/23/2012US20120216318 Nucleic acid molecules and other molecules associated with plants
08/23/2012US20120216317 Nucleotide sequences and polypeptides encoded thereby useful for increasing plant size and increasing the number and size of leaves
08/23/2012US20120216316 Amylopectin Type Starch with Enhanced Retrogradation Stability
08/23/2012US20120216315 Methods in Increasing Grain Value by Improving Grain Yield and Quality
08/23/2012US20120216314 Gene capable of imparting environmental stress resistance to plants and method for utilizing the same
08/23/2012US20120216312 Inbred squash line kaza121
08/23/2012US20120216306 Pea cultivar fp2291
08/23/2012US20120216305 Pea cultivar fp2311
08/23/2012US20120216303 Novel therapeutic uses of human formyl peptide receptor antagonists
08/23/2012US20120215018 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
08/23/2012US20120214975 Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof
08/23/2012US20120214972 Compositions and methods for modulating lymphocyte activity
08/23/2012US20120214970 High Stability Streptavidin Mutant Proteins
08/23/2012US20120214965 Glargine proinsulin and methods of producing glargine insulin analogs therefrom
08/23/2012US20120214964 Liquid insulin compositions and methods of making the same
08/23/2012US20120214963 Aspart proinsulin compositions and methods of producing aspart insulin analogs therefrom
08/23/2012US20120214866 Treatment with cytokines
08/23/2012US20120214865 Methods for slowing familial als disease progression
08/23/2012US20120214863 Anti-miR-1 Therapy for Wound Healing
08/23/2012US20120214861 Methods and compositions for treating neurological disease
08/23/2012US20120214744 Polypeptides and nucleic acids for treating erbb2-dependent cancers
08/23/2012US20120214737 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by nrg-2
08/23/2012US20120214736 Compositions and methods for the modulation of jnk proteins
08/23/2012US20120214709 Isolating biological modulators from biodiverse gene fragment libraries
08/23/2012US20120214703 Methods for Diagnosing Stomach Cancer Using MicroRNA Signatures
08/23/2012US20120214702 Methods for Diagnosing Prostate Cancer Using MicroRNA Signatures
08/23/2012US20120214701 Methods for Diagnosing Lung Cancer Using MicroRNA Signatures
08/23/2012US20120214700 Methods for Diagnosing Colon Cancer Using MicroRNA Signatures
08/23/2012US20120214699 Methods for Diagnosing Breast Cancer Using MicroRNA Signatures
08/23/2012US20120214698 Methods for Diagnosing Stomach Cancer Using MicroRNAs
08/23/2012US20120214697 Methods for Diagnosing Prostate Cancer Using MicroRNAs
08/23/2012US20120214696 Methods for Diagnosing Pancreatic Cancer Using MicroRNAs
08/23/2012US20120214695 Methods for Diagnosing Lung Cancer Using MicroRNAs
08/23/2012US20120214694 Methods for Diagnosing Colon Cancer Using MicroRNAs
08/23/2012US20120214693 Methods for Diagnosing Breast Cancer Using MicroRNAs
08/23/2012US20120214692 Methods for Diagnosing Pancreatic Cancer Using miR-103-1, miR-103-2, miR-24-2 and miR-107
08/23/2012US20120214691 Methods for Diagnosing Breast Cancer Using miR-21, miR-125-1, miR-125b-2 and miR-145
08/23/2012US20120214690 Methods for Diagnosing Colon, Stomach, Prostate and Pancreas Cancer Using miR-223
08/23/2012US20120214689 Methods for Diagnosing Breast and Lung Cancer Using miR-210 and miR-213
08/23/2012US20120214688 Methods for Diagnosing Breast, Colon, Lung, Pancreatic and Prostate Cancer Using miR-21 and miR-17-5p
08/23/2012US20120214687 Baff receptor (bcma), an immunoregulatory agent
08/23/2012US20120214681 Multiplexed Analysis Of Polymorphic Loci By Concurrent Interrogation And Enzyme-Medicated Detection
08/23/2012US20120214243 Method of efficiently establishing induced pluripotent stem cells
08/23/2012US20120214242 Cre-lox based gene knockdown constructs and methods of use thereof
08/23/2012US20120214241 Zinc finger nuclease modification of leucine rich repeat kinase 2 (lrrk2) mutant fibroblasts and ipscs
08/23/2012US20120214240 Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same
08/23/2012US20120214228 Tal effector-mediated dna modification
08/23/2012US20120214221 Methods For Monitoring Multiple Gene Expression
08/23/2012US20120214214 Transformant and process for production thereof, and process for production of lactic acid
08/23/2012US20120214208 Fusion polypeptides and uses thereof
08/23/2012US20120214206 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
08/23/2012US20120214200 Prokaryotic expression construct
08/23/2012US20120214199 Lis-pro proinsulin compositions and methods of producing lis-pro insulin analogs therefrom
08/23/2012US20120214197 Polypeptides Having Glucoamylase Activity and Polynucleotides Encoding Same
08/23/2012US20120214196 Polypeptides Having Glucoamylase Activity And Polynucleotides Encoding Same
08/23/2012US20120214188 Light-activated ion channel molecules and uses thereof
08/23/2012US20120214170 Cellular depletion of biomolecular targets
08/23/2012US20120214164 Dna sequencing method
08/23/2012US20120214163 Disease-associated genetic variations and methods for obtaining and using same
08/23/2012US20120213888 Cloning, expression and use of acid phospholipases
08/23/2012US20120213848 Treatment of Infection Using Single Chain Antibody Gene Therapy
08/23/2012US20120213834 Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
08/23/2012US20120213828 Adenovirus vaccine vector and methods of use
08/23/2012US20120213815 Vaccines and immunotherapeutics using codon-optimized il-15 and methods for using the same
08/23/2012US20120213810 Novel european prrsv strain
08/23/2012US20120213809 Vault complexes for cytokine delivery
08/23/2012US20120213799 Compositions and methods for treating inflammatory disorders
08/23/2012US20120213794 Ax213 and ax132 psck9 antagonists and variants
08/23/2012US20120213790 Methods of treatment using il-16 antagonist peptides
08/23/2012US20120213787 Stable anti-tnfr1 polypeptides, antibody variable domains & antagonists
08/23/2012US20120213783 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
08/23/2012US20120213782 Bmp10 antibodies and related methods
08/23/2012US20120213781 Monovalent and Multivalent Multispecific Complexes and Uses Thereof
08/23/2012US20120213780 Efficient mucosal vaccination mediated by the neonatal Fc receptor
08/23/2012US20120213779 Fgf21 mutants and uses thereof
08/23/2012US20120213778 Method of detecting and treating tuberous sclerosis complex associated disorders
08/23/2012US20120213777 Vascular endothelial growth factor 2
08/23/2012US20120213774 Antibodies against human IL33R and uses thereof
08/23/2012US20120213771 Antibodies that bind human cd27 and uses thereof
08/23/2012US20120213767 Extended Soluble PH20 Polypeptides and uses thereof
08/23/2012US20120213760 Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1(mtm1) polypeptides
08/23/2012US20120213738 Cardiac Repair By Reprogramming of Cardiac Fibroblasts Into Cardiomyocytes
08/23/2012US20120213730 Alteration of cell membrane for new functions
08/23/2012US20120213728 Granulocyte-colony stimulating factor produced in glycoengineered pichia pastoris
08/23/2012US20120213705 ENGINEERED Fc REGIONS FOR SITE-SPECIFIC CONJUGATION
08/23/2012US20120213699 Single chain fragment of monoclonal antibody 9b9 and uses thereof
08/23/2012DE112010004383T5 Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung Plants having enhanced yield-related traits and processes for their preparation
08/23/2012CA2827618A1 Compositions and methods of use for the determination of he4a
08/23/2012CA2827375A1 Improved aav8 vector with enhanced functional activity and methods of use thereof
08/23/2012CA2827348A1 Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
08/23/2012CA2827313A1 Biosynthesis of human milk oligosaccharides in engineered bacteria
08/23/2012CA2827164A1 Saccharomyces cerevisiae strains suitable for the production of baker's yeasts which are osmotolerant and which exhibit intrinsic resistance to weak organic acids, methods for thepreparation thereof and uses
08/23/2012CA2827040A1 Quantitative, highly multiplexed detection of nucleic acids
08/23/2012CA2826714A1 Humanized m-csf mice
08/23/2012CA2826316A1 Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer
08/23/2012CA2826276A1 Root-preferred promoter and methods of use
08/23/2012CA2825794A1 Small interfering rnas with target-specific seed sequences
08/23/2012CA2825243A1 Antibody against the csf-1r
08/22/2012EP2489741A1 Method for production of glutathione or gamma-glutamylcysteine
1 ... 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 ... 4023